Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric

Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

The clinical nutrition market is set to register significant growth through 2030 primarily due to the growing elderly population worldwide. Besides, there is rising awareness regarding health management among the general populace, which is also expected to positively impact the market.

Recently, major players in the industry have been investing in product innovation to improve their business standing, thereby enhancing clinical nutrition market dynamics. For instance, in July 2022, FemTec Health, a health sciences expert, acquired Nutrimedy, the nutrition platform that offers recommendations about nutrition. FemTec planned to integrate the tool into its direct-to-consumer platform, known as Awesome Woman, which not only allows sending products like supplements to customers' homes and at-home tests but also provides telehealth visits.

The clinical nutrition market has been divided in terms of consumer, distribution channel, product, application, and region.

On the basis of distribution channel, the market has been divided into retail stores, pharmacies and drug stores, online channels, and others. Among these, the pharmacies & drug stores segment accounted for about 27.0% revenue share in 2021 and is anticipated to grow sizably through 2030 owing to the easy access and validation of products through licensed pharmacists.

With respect to product, the clinical nutrition market has been divided into infant nutrition, parenteral nutrition, and enteral nutrition. The parenteral nutrition segment is estimated to grow significantly through the analysis timeline on account of the increasing use of parenteral nourishment to cater to the needs of the aging population.

Based on application, the market has been divided into metabolic disorders, gastrointestinal disorders, cancer, neurological diseases, and others. The metabolic disorders segment was valued at over $15,445 million in 2021 and is anticipated to observe robust growth from 2022 to 2030 as a result of mounting prevalence of metabolic diseases. Increasing as well as easy accessibility to products that promote the treatment of metabolic ailments are slated to further facilitate segmental expansion. On the other hand, patients suffering from neurological disorders are at a high risk of dehydration and micronutrient deficiency, which is foreseen to drive the growth of the neurological diseases segment through the review time period.

In the regional context, the clinical nutrition market in Europe is expected to grow significantly up to 2030 backed by soaring number of pediatric patients and a notable surge in chronic diseases. In addition, the market in the Latin America region is set to register significant growth over the forecast period. As per a July 2021 survey, about 39.6% of hospitalized patients in the region were at risk of malnutrition. The growing prevalence of conditions like these is projected to fuel the growth of the LATAM clinical nutrition market in the future.